TNF and inflammatory bowel disease: Another recent case series by Buer et al. evaluated safety and clinical response of combination anti‐TNFα and vedolizumab therapy in 10 patients with IBD and concluded that the combination treatment is safe and might represent a treatment option in selected subjects.16